A Costly Lifeline: Sivers Semiconductors’ Convertible Bond Puts Dilution Front and Centre

Sivers stock surged 990% but borrows at 10.85% via convertible notes; short seller bets against overvaluation as dilution risks loom and revenue growth remains modest.

Sivers Semiconductors finds itself navigating a peculiar paradox. The stock has surged more than 990% over the past twelve months, yet the company is still borrowing at a punishing 10.85% annual rate via a newly detailed convertible bond. That gap between market euphoria and the cost of capital is the defining tension for investors ahead of a packed June calendar.

The terms of the Series I convertible note, released on 20 May, set a maximum principal amount of $11.67 million. Interest is payable monthly in advance, and the conversion price is fixed at 4.77 Swedish kronor per share — a fraction of the current market price. At the time of the announcement, Sivers shares traded at 54.00 SEK on the Stockholm exchange, implying that any conversion would massively dilute existing holders unless the company repurchases or retires the debt.

The bond runs from 6 March 2026 through 31 December 2029, but the conversion period begins as soon as the instrument is registered with the Swedish Companies Registration Office. With the stock trading at more than ten times the conversion price, every conversion would mint new equity at a deep discount, making the dilution question impossible to ignore.

A Rally Under Scrutiny

The scale of the share price move has drawn both admirers and adversaries. Sivers was added to the MSCI indices in early May, sparking a 31.3% surge between 10 and 20 May. On 20 May alone, the stock jumped 18.79%, extending a year-to-date advance that by any measure is extraordinary for a company still reporting net losses.

But the rally has also attracted a prominent bear. Voleon Capital Management disclosed a short position in the Stockholm-listed shares, betting that the valuation has run too far ahead of fundamentals. On the day after the bond terms were published, the stock fell 5.49% to 45.46 SEK, while the US-listed depositary receipts (ticker SIVEF) moved in the opposite direction, closing at $5.81.

Analyst consensus still rates Sivers a “Buy,” but the average price target stands at a mere 6.55 SEK — a stark reminder of how far the current price has overshot traditional valuation models. The market capitalisation has ballooned to roughly $1.72 billion, a level that rests entirely on future growth expectations rather than today’s earnings.

Losses Persist as Revenue Growth Remains Modest

The company will face its first real test of that narrative on 29 May, when it reports first-quarter 2026 results. In the fourth quarter of 2025, revenue was 80.7 million SEK, while the net loss came in at 23.67 million SEK. Free cash flow remained deeply negative. Investors will be looking for signs that the loss trajectory is narrowing, or at least that the top line is accelerating.

On the positive side, Sivers recently secured a $1.5 million development contract with Tachyon. The sum is modest, but it signals progress in the company’s project pipeline and could bolster confidence that its photonics and semiconductor technology is moving toward commercialisation.

Board Overhaul Points to Nasdaq Ambitions

The company is also preparing for a potentially transformative shift: a secondary listing on the Nasdaq in the United States. The nomination committee has proposed reshaping the board ahead of the annual general meeting on 15 June. It recommends electing Joakim Nideborn, a former CFO, as deputy chairman, along with Helena Svancar as a new member. Incumbents Dr Bami Bastani, Todd Thomson and Karin Raj are slated for re-election, while Tomas Duffy, Erik Fallstrom and Keith Halsey are set to exit.

A US listing would raise Sivers’ profile and give it better access to deeper capital pools, but it also demands stricter governance and disclosure standards. The board shake-up appears designed to meet those requirements.

External tailwinds lend credibility to the strategic pivot. The European Union’s Chips Act targets a 20% global market share for European semiconductor manufacturing by 2030, and Brussels recently approved €288 million in state aid for German chip projects. Meanwhile, the UK has launched a £500 million Sovereign AI Fund.

The Calendar That Could Determine the Next Leg

Between now and 15 June, the market will have to digest three events in quick succession: the Q1 earnings release on 29 May, the publication of the formal notice for the AGM, and the registration of the convertible bond with the Swedish Companies Registration Office.

As long as the stock trades far above 4.77 SEK, the dilution overhang will remain a central part of the debate. Whether that overhang is manageable or explosive depends entirely on whether Sivers can convert its technical promise into the kind of financial performance that justifies a $1.7 billion price tag.